StockData
Carlsmed, Inc. logo

Carlsmed, Inc. (CARL) stock

CARLNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 5/30118% above fair value
$17.74+0.39 (+2.25%)

Close on Nov 17, 2026Market cap $484.35MP/E –Yield –

Carlsmed EPS

Diluted earnings per share is net income divided by the share count including options and convertible securities.

Carlsmed's EPS for the twelve months ending Sep 30, 2025 was -$4.48. For fiscal 2025 it was -$2.12.

Annual eps

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$2.12–
FY2024Dec 31, 2024-$6.11–

Quarterly eps

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$0.39–
Q1 FY2026Mar 31, 2026-$0.32–
Q3 FY2025Sep 30, 2025-$0.40–
Q2 FY2025Jun 30, 2025-$1.47–
Q1 FY2025Mar 31, 2025-$1.47–
Q4 FY2024Dec 31, 2024-$1.14–
Q3 FY2024Sep 30, 2024-$2.06–
Q2 FY2024Jun 30, 2024-$1.55–

More Carlsmed figures

See a number that looks wrong?